← Human Trials & Peer-Reviewed Studies
Clinical and Metabolic Response to Vitamin D Supplementation in Endometrial Hyperplasia: a Randomized, Double-Blind, Placebo-Controlled Trial.
Plain-language guide to PMID 28283863 (2017): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 60 women, endometriosis.
Key Facts
- PMID
- 28283863
- Journal
- Hormones & cancer
- Year
- 2017
- Study type
- Randomized Controlled Trial
- Authors
- Tabassi Z et al. (7 authors)
- DOI
- 10.1007/s12672-017-0290-9
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc in the context of endometriosis and hyperparathyroidism.
This research was done to evaluate the effects of vitamin D supplementation on clinical response and metabolic status of patients with EH.
Why It Was Studied
However, the researchers are not aware of any study evaluating the effects of vitamin D supplementation on clinical response and metabolic status of patients with endometrial hyperplasia (EH).
This randomized, double-blind, placebo-controlled trial was conducted among 60 women diagnosed with EH.
Who Took Part
The abstract describes 60 women taking part.
PubMed tags the participants as women only.
How the Study Was Run
The design is described as randomized, double-blind and placebo-controlled.
Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.
As a double-blind Vitamin D, K2, Magnesium and Zinc study, the assignments were hidden from both participants and investigators until the end.
Some women received a placebo instead of Vitamin D, K2, Magnesium and Zinc, giving a reference point.
What Was Measured
However, the researchers are not aware of any study evaluating the effects of vitamin D supplementation on clinical response and metabolic status of patients with endometrial hyperplasia (EH).
PubMed files the paper under topics including Antioxidants, Blood Glucose, C-Reactive Protein, Dietary Supplements, Endometrial Hyperplasia, Insulin Resistance and Oxidative Stress.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 60 women in people with endometriosis.
The publication is from 2017 (Hormones & cancer), a journal based in United States.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, Endometriosis research, Hyperparathyroidism research.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.